Loading clinical trials...
Loading clinical trials...
Young Adults With Early-onset Obesity Treated With Semaglutide -The RESETTLE Study
Conditions
Interventions
TCOC treatment
Semaglutide 3 mg/ml
+1 more
Locations
2
Denmark
Holbæk University Hospital
Holbæk, Region Zeeland, Denmark
University of Copenhagen, Department of Biomedical Sciences
Copenhagen, Denmark
Start Date
June 1, 2022
Primary Completion Date
April 30, 2026
Completion Date
April 30, 2026
Last Updated
December 18, 2025
NCT06822387
NCT05982847
NCT04766801
NCT06865365
NCT05966870
NCT06698835
Lead Sponsor
Signe Torekov
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions